Food and Drug Administration
Blood Products Advisory Committee
December 14, 2001
Briefing Information
Topic III. Human Cells, Tissues and Cellular and Tissue-Based Products: Risk Factors for Semen Donation
Introduction and Background, Antonio Pereira, MD, FDA [pdf version] [htm version] [Word version]
Incidence and Prevalence of HIV, HBV, HCV and Other STDs Among High Risk Groups, Linda A Valleroy, PhD, CDC [ppt version] [htm version]
Human Herpesvirus 8 (HHV-8) as an Emerging Pathogen: Relevance to Semen Donation, Michael J. Cannon, Ph.D., CDC [ppt version] [htm version]
Draft - The biology of window period infections: implications for donor screening and inventory hold, Dr. Steven Kleinman [ppt version] [htm version]
Fundamental Cryobiology of Human Spermatozoa and its Relationship to Artificial Insemination Outcomes, John K. Critser, Ph.D., Director, Comparative Medicine Center, Gilbreath-McLorn Professor of Comparative Medicine, University of Missouri-Columbia [pdf version] [htm version] [Word version]
Achieving Pregnancy Using Fresh Versus Cryopreserved Semen for Donor Insemination, Emmet J Lamb MD (New 12/10/01) [ppt version] [htm version]
Annotated bibliography of studies in the meta-analysis, Emmet J Lamb MD (New 12/10/01) [Word version] [htm version] [pdf version]
Complex Meta-Analysis Table, Emmet J Lamb MD (New 12/10/01) [xls version] [pdf verison]
Bibliography Topic III [pdf version] [htm version] [Word version]
Open Public Hearing
September 8, 2001 Letter to the Blood Products Advisory Committee from Leland Traiman, RN/FNP [pdf version]
December 28, 1999 letter to Dockets Management Branch, Docket Number 97N-484S, from Lambda Legal Defense and Education Fund, Inc. from Doni Gewirtzman [pdf version]
May 17, 1999 Letter to the Editor [pdf version]
Sperm Literature Review [pdf version]
Study of HIV Incidence, Leland Traiman RN/FNP, Fred Strauss, MD, Steward Blandon, MD [pdf version]